Sarepta Therapeutics Aktie
WKN DE: A1J1BH / ISIN: US8036071004
30.07.2013 15:31:00
|
Critical Alerts For Citigroup, JPMorgan, Time Warner Cable, TakeTwo Interactive, and Sarepta Therapeutics Released By InvestorsObserver
CHICAGO, July 30, 2013 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for C, JPM, TWC, TTWO, and SRPT.
To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/72920130 (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover the following stocks: Citigroup (NYSE: C), JPMorgan (NYSE: JPM), Time Warner Cable (NYSE: TWC), TakeTwo Interactive (Nasdaq: TTWO), and Sarepta Therapeutics (Nasdaq: SRPT).
InvestorsObserver's PriceWatch Alerts contain concise, detailed strategies for each stock we cover, including position protection tactics designed to defend investors from potential market shifts. While many other market reports only provide stock news and opinion, we offer strategies that can bulwark investments against uncertainty and increase chances of making a profit, even if a stock goes down.
"We go above and beyond typical market coverage," said Bobby Raines, Analyst at InvestorsObserver. "Trading experts and beginning investors alike can find value in our PriceWatch Alerts. We provide actionable strategies that protect investments with basic hedging tactics, along with a concise explanation of our techniques."
For essential information on stocks poised to move go to:
http://www.investorsobserver.com/pr/72920130 for InvestorsObserver's PriceWatch Alerts.
InvestorsObserver.com is an online newsletter which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help subscribers make the best possible investment decisions. For more information go to www.investorsobserver.com.
All stocks and options shown are examples only-- not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes--expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available at http://www.cboe.com/Resources/Intro.aspx. Privacy policy available upon request.
SOURCE InvestorsObserver

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Citigroup Inc.mehr Nachrichten
21.04.25 |
S&P 500-Wert Citigroup-Aktie: So viel Gewinn hätte ein Citigroup-Investment von vor 3 Jahren abgeworfen (finanzen.at) | |
15.04.25 |
NYSE-Handel S&P 500 fällt nachmittags (finanzen.at) | |
15.04.25 |
Citi-Aktie höher: Citigroup überzeugt mit starkem Gewinnanstieg (dpa-AFX) | |
15.04.25 |
ROUNDUP: Auch Bank of America und Citigroup profitieren von Marktunsicherheiten (dpa-AFX) | |
15.04.25 |
Ausblick: Citigroup veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
14.04.25 |
S&P 500-Titel Citigroup-Aktie: So viel hätten Anleger an einem Citigroup-Investment von vor einem Jahr verdient (finanzen.at) | |
07.04.25 |
S&P 500-Wert Citigroup-Aktie: So viel hätten Anleger an einem Citigroup-Investment von vor 10 Jahren verdient (finanzen.at) | |
31.03.25 |
S&P 500-Papier Citigroup-Aktie: So viel hätte eine Investition in Citigroup von vor 5 Jahren abgeworfen (finanzen.at) |
Analysen zu Citigroup Inc.mehr Analysen
Aktien in diesem Artikel
Citigroup Inc. | 60,27 | 0,52% |
|
JPMorgan Chase & Co. | 214,60 | 0,54% |
|
Sarepta Therapeutics Inc. | 52,92 | 0,04% |
|
Take Two | 199,96 | 1,45% |
|